WANITA LISTER: Open Payments
NPI 1467893172 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 18 payments from 11 companies in 2025. Trend: 2023 $93 · 2024 $113 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| ABBVIE INC. | 2 | $30 |
| Lundbeck LLC | 1 | $29 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: REXULTI, INGREZZA, MOUNJARO, The Cologuard Plus Collection Kit, SPRAVATO, VRAYLAR, Quviviq, CAPLYTA.
Industry payments across MO — which companies pay providers there.
